Olympic Ophthalmics wins FDA nod for iTEAR100 neurostimulator

Olympic Ophthalmics announced today that it received FDA de novo clearance for its iTEAR100 neurostimulation technology for acute tear production. The Issaquah, Wash.-based company’s prescription iTEAR100 system stimulates a cutaneous nerve to temporarily increase acute tear production in adults. Olympic Ophthalmics’ neurostimulator is a stand-alone, pocket-size device that requires a 30-second-or-less application to the skin … Continue reading Olympic Ophthalmics wins FDA nod for iTEAR100 neurostimulator